Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. [electronic resource]
- Frontiers in immunology 2019
- 1520 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't